Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/24/20241:18AMPR Newswire (Canada)Xinhua Silk Road : La marque chinoise de baijiu Wuliangye met en lumière les échanges culturels entre la Chine et le Chili par l'entremise d'une tournée mondiale élaborée
04/24/20241:15AMBusiness WireEurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its ObjectivesNYSE:ERFEnerplus Corporation
04/24/20241:03AMBusiness WireKalray Joins Arm Total Design, Extending Collaboration With Arm on Accelerated AI ProcessingEU:ALKALKALRAY SA
04/24/20241:03AMBusiness WireKALRAY DEVIENT MEMBRE DU PROGRAMME « ARM TOTAL DESIGN », RENFORÇANT SA COLLABORATION AVEC ARM SUR L’IA ET L’ACCÉLÉRATION DU TRAITEMENT DES DONNÉESEU:ALKALKALRAY SA
04/24/20241:00AMGlobeNewswire Inc.NaaS Technology and its Parent Company, NewLink, Join the Open Invention Network CommunityNASDAQ:NAASNaaS Technology Inc
04/24/20241:00AMGlobeNewswire Inc.Melexis Q1 2024 résultats – Chiffre d'affaires de 241.8 millions d'euros au premier trimestreTG:MEXMelexis
04/24/20241:00AMGlobeNewswire Inc.IMCD Spain expands its Pharmaceuticals presence with the acquisition of CobapharmaTG:INXIMCD NV
04/24/20241:00AMGlobeNewswire Inc.Melexis Q1 2024 results – First quarter sales of 241.8 million EUREU:MELEMelexis
04/24/20241:00AMGlobeNewswire Inc.Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidanceEU:IPNIpsen SA
04/24/20241:00AMGlobeNewswire Inc.Melexis Q1 2024 résultats – Chiffre d'affaires de 241.8 millions d'euros au premier trimestreEU:MELEMelexis
04/24/20241:00AMGlobeNewswire Inc.BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023EU:BIOSBiosenic
04/24/20241:00AMGlobeNewswire Inc.First quarter 2024 financial information: Good start to the yearEU:NEXNexans
04/24/20241:00AMGlobeNewswire Inc.Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic UpdatesTG:05YVivoryon Therapeut
04/24/20241:00AMGlobeNewswire Inc.Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic UpdatesLSE:0R3MVivoryon Therapeutics Nv
04/24/20241:00AMGlobeNewswire Inc.Information financière du premier trimestre 2024: Bon début d'annéeEU:NEXNexans
04/24/20241:00AMGlobeNewswire Inc.TGS Q1 2024 Presentation and WebcastTG:TGCTGS ASA
04/24/20241:00AMGlobeNewswire Inc.Norsk Hydro: Resilient in weak markets, positioned for growthTG:NHYLucapa Diamond Company Ltd
04/24/20241:00AMGlobeNewswire Inc.Vopak reports strong Q1 2024 results and increases FY 2024 outlookEU:VPKKoninklijke Vopak
04/24/20241:00AMGlobeNewswire Inc.BioSenic reporte son assemblée générale annuelle des actionnaires et fournit des chiffres financiers temporaires non-audités pour 2023LSE:0R55Bone Therapeutics Sa
04/24/20241:00AMGlobeNewswire Inc.Start of Day Message
04/24/20241:00AMGlobeNewswire Inc.Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l'exercice 2024TG:I7GIpsen SA
04/24/20241:00AMGlobeNewswire Inc.Melexis Q1 2024 results – First quarter sales of 241.8 million EURTG:MEXMelexis
04/24/20241:00AMBusiness WireCARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024EU:ALCARCarmat
04/24/20241:00AMGlobeNewswire Inc.Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic UpdatesEU:VVYVivoryon Therapeut
04/24/20241:00AMGlobeNewswire Inc.Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsEU:PHARMPharming Group NV
04/24/20241:00AMGlobeNewswire Inc.First quarter 2024 financial information: Good start to the yearEU:NEXNexans
04/24/20241:00AMGlobeNewswire Inc.Information financière du premier trimestre 2024: Bon début d'annéeTG:NXSNexans
04/24/20241:00AMBusiness WireElliptic Labs Shipping Its AI Software Platform on Lenovo’s Newest ThinkPad™ P Series Workstation Laptops
04/24/20241:00AMGlobeNewswire Inc.Borregaard ASA: EBITDA1 of NOK 442 million in the 1st quarterTG:BO4Borregaard ASA
04/24/20241:00AMGlobeNewswire Inc.Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsTG:PHGNPharming Group NV